Showing results (81-90 of 210) with videos related to
Sort By:
Pageof 21
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Predicting lymphoma outcomes and risk factors in patients with primary Sjögren's Syndrome using gradient boosting tree ensemblesVasileios C Pezoulas, Themis P Exarchos, Athanasios G Tzioufas, et al.Clinical and Experimental Rheumatology|January 31, 2017
Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitisSophia Lionaki, George E Fragoulis, Aliki Venetsanopoulou, et al.Autoimmunity Reviews|September 15, 2018
How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort studyChristos F Kampolis, Aliki I Venetsanopoulou, Foteini Karakontaki, et al.Frontiers in Immunology|September 13, 2021
COVID-19 Immunobiology: Lessons Learned, New Questions AriseAimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, et al.Clinical Rheumatology|September 16, 2017
Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective studyGeorge E Fragoulis, Sophia Lionaki, Aliki Venetsanopoulou, et al.The Journal of Infectious Diseases|August 19, 2011
Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemiaAristotelis Tsiakalos, John G Routsias, Theodore Kordossis, et al.Frontiers in Immunology|September 6, 2021
Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's SyndromeLoukas Chatzis, Andreas V Goules, Ioanna E Stergiou, et al.Autoimmunity|August 20, 2015
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4Eleni I Kampylafka, Harry Alexopoulos, Avraam El Hamidieh, et al.Patterns (New York, N.Y.)|January 24, 2024
FHBF: Federated hybrid boosted forests with dropout rates for supervised learning tasks across highly imbalanced clinical datasetsVasileios C Pezoulas, Fanis Kalatzis, Themis P Exarchos, et al.Medicine|May 29, 2015
Clinical and laboratory predictors of distinct histopathogical features of lupus nephritisClio P Mavragani, George E Fragoulis, George Somarakis, et al.Pageof 21